Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, 3814, Bangladesh.
Department of Microbiology, Noakhali Science and Technology University, Sonapur, Noakhali, 3814, Bangladesh.
Biomed Pharmacother. 2020 Dec;132:110942. doi: 10.1016/j.biopha.2020.110942. Epub 2020 Nov 1.
Aeginetia indica, a perennial herb from the Orobanchaceae family, generally grows as a root parasite and is widely distributed in the forests of South and South-Asian countries. The plant has valuable uses in herbal medicine against various diseases, such as diabetes, liver diseases, and arthritis.
The present study was designed to investigate the antidiabetic and hepatoprotective effects of the methanol extract of the whole plant of A. indica in a mouse model followed by the isolation of bioactive compounds and their in-silico studies.
The hepatoprotective effects were evaluated in a paracetamol-induced hepatotoxicity mouse model. The antidiabetic effects were examined by an oral glucose tolerance test and in an alloxan-induced diabetes mouse model.
The plant extract, at a dose of 400 mg/kg, caused a significant reduction (p < 0.001) in liver enzyme concentrations, including alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase, similar to the effects of standard drug silymarin. The plant extract, at 400 mg/kg, also significantly reduced (p < 0.001) the fasting blood glucose concentration by 27.33 % after 3 h, compared with a reduction of 45.31 % in response to glibenclamide. In the alloxan-induced diabetes model mice, significant reductions (p < 0.05) in elevated glucose concentrations were observed on days 10 and 20 in mice treated with plant extract and glibenclamide. Chromatographic analyses and nuclear magnetic resonance (NMR) studies identified the presence of β-sitosterol, stigmasterol, and oleic acid in the extract. The possible mechanism underlying the antidiabetic effects was revealed by molecular docking analyses examining the binding of β-sitosterol and stigmasterol with sirtuin 4, an NAD-dependent deacylase enzyme that downregulates leucine-induced and glutamate dehydrogenase-induced insulin secretion. The binding affinities between sirtuin 4 and β-sitosterol, stigmasterol, and NAD were found to be -8.6 kcal/mol, -7.2 kcal/mol and -9.5 kcal/mol, respectively, indicating the probable competition between NAD and the isolated components for sirtuin 4.
The present study revealed that A. indica exerted protective effects against alloxan-induced diabetes and paracetamol-induced hepatotoxicity in mice, which supports the findings regarding the use of A. indica during traditional medical practice.
印度匙羹藤,玄参科多年生草本植物,一般作为根寄生植物生长,广泛分布于南亚和东南亚国家的森林中。该植物在草药治疗各种疾病方面具有重要价值,如糖尿病、肝病和关节炎。
本研究旨在探讨印度匙羹藤全草甲醇提取物在小鼠模型中的抗糖尿病和保肝作用,并对生物活性化合物进行分离及其计算机模拟研究。
在对乙酰氨基酚诱导的肝毒性小鼠模型中评价其保肝作用。通过口服葡萄糖耐量试验和链脲佐菌素诱导的糖尿病小鼠模型评价其抗糖尿病作用。
植物提取物在 400mg/kg 剂量下,可显著降低(p<0.001)丙氨酸转氨酶、天冬氨酸转氨酶和碱性磷酸酶等肝酶浓度,作用与标准药物水飞蓟素相似。该植物提取物在 400mg/kg 剂量下,还可使 3 小时后空腹血糖浓度显著降低(p<0.001),降幅为 27.33%,而格列本脲的降幅为 45.31%。在链脲佐菌素诱导的糖尿病模型小鼠中,植物提取物和格列本脲治疗组在第 10 天和第 20 天可显著降低(p<0.05)血糖浓度升高。色谱分析和核磁共振(NMR)研究表明,提取物中存在β-谷甾醇、豆甾醇和油酸。分子对接分析揭示了抗糖尿病作用的可能机制,即考察了β-谷甾醇和豆甾醇与烟酰胺腺嘌呤二核苷酸(NAD)依赖性脱酰酶 sirtuin 4 的结合情况,后者下调亮氨酸诱导和谷氨酸脱氢酶诱导的胰岛素分泌。发现 sirtuin 4 与β-谷甾醇、豆甾醇和 NAD 的结合亲和力分别为-8.6kcal/mol、-7.2kcal/mol 和-9.5kcal/mol,表明 NAD 和分离成分可能与 sirtuin 4 竞争。
本研究表明,印度匙羹藤对小鼠的链脲佐菌素诱导糖尿病和对乙酰氨基酚诱导肝毒性具有保护作用,这支持了印度匙羹藤在传统医学实践中的应用。